Interested in developing cardioprotective drugs?

Join Nirupama Pike at the Precision Medicine & Bioprocessing Conference June 8th in the San Francisco Bay Area where she will be speaking about a unique combination of SMarTR bioinformatics and cardiomyocyte screening that allows for the development of novel cardioprotective drugs.

The conference will feature selected keynote presentations by precision medicine-focused biotechnology companies developing novel therapies for heart failure, cancer and resourceful technology platforms addressing a broad range of diseases.